Navigation Links
Brookhaven scientists explore brain's reaction to potent hallucinogen
Date:4/28/2008

UPTON, NY - Brain-imaging studies performed in animals at the U.S. Department of Energys (DOE) Brookhaven National Laboratory provide researchers with clues about why an increasingly popular recreational drug that causes hallucinations and motor-function impairment in humans is abused. Using trace amounts of Salvia divinorum also known as salvia, a Mexican mint plant that can be smoked in the form of dried leaves or serum Brookhaven scientists found that the drugs behavior in the brains of primates mimics the extremely fast and brief high observed in humans. Their results are now published online in the journal NeuroImage.

Quickly gaining popularity among teenagers and young adults, salvia is legal in most states, but is grabbing the attention of municipal lawmakers. Numerous states have placed controls on salvia or salvinorin A the plants active component and others, including New York, are considering restrictions.

This is probably one of the most potent hallucinogens known, said Brookhaven chemist Jacob Hooker, the lead author of the study, which is the first to look at how the drug travels through the brain. Its really important that we study drugs like salvia and how they affect the brain in order to understand why they are abused and to investigate their medicinal relevance, both of which can inform policy makers.

Hooker and fellow researchers used positron emission tomography, or PET scanning, to watch the distribution of salvinorin A in the brains of anesthetized primates. In this technique, the scientists administer a radioactively labeled form of salvinorin A (at concentrations far below pharmacologically active doses) and use the PET scanner to track its site-specific concentrations in various brain regions.

Within 40 seconds of administration, the researchers found a peak concentration of salvinorin A in the brain nearly 10 times faster than the rate at which cocaine enters the brain. About 16 minutes l
'/>"/>

Contact: Kendra Snyder
ksnyder@bnl.gov
631-344-8191
DOE/Brookhaven National Laboratory
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists Discover How Stomach Tumors Form
2. U.S. Scientists Receive Japan Prize on April 23, 2008
3. Scientists discover a mechanism that can send cells on the road to cancer
4. Scientists identify novel way to prevent cardiac fibrosis
5. Scientists Explore Human Gene Pool With Help From Microsoft Research
6. Scientists obtain anticancer medicines from the elecampe, a wild plant growing in the Mediterranean
7. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
8. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
9. Stem cells and cancer: Scientists investigate a fine balancing act
10. Scientists Block Prostate Cancer Cells Spread
11. Scientists solve mystery of polyketide drug formation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...ing based on the ‘survival of the fittest’ theory,...a motive to nurture// the healthy ones, has borne ...ple, the first in UK, after successfully employing...y prone to a condition called cystic fibrosis, a g...
... choice for treatment of influenza is causing pand...sychiatric// side effects, regulators said today. ...fter series of cases of self-injury and mental dis...l approved by U.S FDA cautions medical practitione...
...utt and Yujiang Song from Sandia National Laborat... how a drug attaches //to a cell which involves a ...ctures. Sandia is a National Nuclear Security Admi... currently published the same as an advance public...
...s may do little to improve the use of continuous p...th obstructive sleep apnea (OSA). A new study publ...iewed journal of the American College of Chest Phy...OSA taking a placebo. “CPAP treatment improve...
... and a half years old, is reported to have died fr...spital on Sunday. //The toddler from West Java pro...estic fowl. With this, the death toll, due to this... not related. Most of those affected have caug...
...an opportune time to evaluate the support availabl...orld coping with a galloping disease. Taking// cog...06 - 'Diabetes Care for Everyone, especially the d...w attention towards the communities and groups in ...
Other Medicine News:Health News:Caution:Tamiflu ‘tames’ flu but psychiatric side effects now report 2Health News:Novel methods to view how a drug attaches to a cell 2Health News:Research Questions Use of Sleep Meds for Patients with Apnea 2Health News:The Holy Grail of Diabetes Management 2Health News:The Holy Grail of Diabetes Management 3
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers of the AcceleDent System , which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 1Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 2Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 6055 1Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 6055 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 1NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 5
...Department of,Health "unveiled a brand new look fo...a campaign to encourage New Yorker,s to ,get some....uld hand out free condoms at,"busy crossroads," th...and,display ads on subway cars and phone kiosks, a...t year., Robert Peters, President of MIM had the ...
...located in,Houston, Global Healing Center, Inc., a...studies indicating their oxygen colon cleanser is ...tipation and Irritable Bowel,Syndrome. In fact, th...ansing supplement is up to 85% MORE EFFECTIVE AT E... with a zero-percent failure rate., Colon cleansi...
Other Medicine Technology:NYC Department of Health's 'Get Some NYC Condoms' Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters 2Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies 2
Straight Tissue Forceps
Sanders-Castroviejo Suturing Forceps
Storz Bonn Suturing Forceps
Berens Curved Suturing Forceps
Medicine Products: